Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144
Robb, Merlin L, MD, Rerks-Ngarm, Supachai, MD, Nitayaphan, Sorachai, MD, Pitisuttithum, Punnee, Prof, Kaewkungwal, Jaranit, PhD, Kunasol, Prayura, MD, Khamboonruang, Chirasak, MD, Thongcharoen, Prasert, Prof, Morgan, Patricia, MS, Benenson, Michael, MD, Paris, Robert M, MD, Chiu, Joseph, MD, Adams, Elizabeth, MD, Francis, Donald, MD, Gurunathan, Sanjay, MD, Tartaglia, Jim, PhD, Gilbert, Peter, PhD, Stablein, Don, PhD, Michael, Nelson L, MD, Kim, Jerome H, Dr
Published in The Lancet infectious diseases (01.07.2012)
Published in The Lancet infectious diseases (01.07.2012)
Get full text
Journal Article